A detailed history of Capula Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Capula Management LTD holds 11,700 shares of PFE stock, worth $321,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,700
Previous 32,898 64.44%
Holding current value
$321,282
Previous $912,000 64.14%
% of portfolio
0.0%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $24,426 - $28,623
-967 Reduced 2.94%
31,931 $893,000
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $851,729 - $978,057
32,898 New
32,898 $912,000
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $339,961 - $397,380
10,594 New
10,594 $351,000
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $3.43 Million - $4.46 Million
86,963 New
86,963 $3.55 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $386,269 - $471,538
8,827 New
8,827 $386,000
Q1 2022

May 17, 2022

BUY
$45.75 - $56.69 $10,065 - $12,471
220 New
220 $11,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $1.36 Million - $2.01 Million
-32,876 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $894,311 - $1.15 Million
-22,785 Reduced 40.94%
32,876 $1.41 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1.6 Million - $1.81 Million
44,593 Added 402.9%
55,661 $2.16 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $370,667 - $418,038
11,068 New
11,068 $401,000
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $9.68 Million - $11.4 Million
-304,950 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $4.91 Million - $5.96 Million
163,067 Added 114.93%
304,950 $9.97 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $3.84 Million - $5.48 Million
141,883 New
141,883 $4.63 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.